RBC Capital Starts ARIAD Pharmaceuticals (ARIA) at Outperform
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.78 --0%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
RBC Capital initiates coverage on ARIAD Pharmaceuticals (NASDAQ: ARIA) with an Outperform. PT $20.00.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $15.25 yesterday.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $15.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
- Wells Fargo Starts Huntington Bancshares (HBAN) at Overweight
- Citi Resumes Universal Music Group NV (UMG:NA) (UMGNF) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
